CAMG Solamere Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $872K | Hold |
20,273
| – | – | 0.72% | 52 |
|
|
2021
Q2 | $794K | Sell |
20,273
-27,993
| -58% | -$1.1M | 0.69% | 54 |
|
|
2021
Q1 | $1.75M | Sell |
48,266
-1,729
| -3% | -$62.7K | 1.51% | 23 |
|
|
2020
Q4 | $1.84M | Sell |
49,995
-38,136
| -43% | -$1.41M | 1.55% | 18 |
|
|
2020
Q3 | $3.07M | Buy |
88,131
+197
| +0.2% | +$6.86K | 1.71% | 12 |
|
|
2020
Q2 | $2.73M | Sell |
87,934
-2,244
| -2% | -$69.6K | 1.5% | 13 |
|
|
2020
Q1 | $2.79M | Buy |
90,178
+52,684
| +141% | +$1.63M | 1.47% | 23 |
|
|
2019
Q4 | $1.4M | Sell |
37,494
-627
| -2% | -$23.3K | 0.64% | 48 |
|
|
2019
Q3 | $1.3M | Hold |
38,121
| – | – | 0.65% | 48 |
|
|
2019
Q2 | $1.57M | Hold |
38,121
| – | – | 0.72% | 45 |
|
|
2019
Q1 | $1.54M | Sell |
38,121
-427
| -1% | -$17.2K | 0.76% | 44 |
|
|
2018
Q4 | $1.6M | Buy |
38,548
+206
| +0.5% | +$8.53K | 0.89% | 43 |
|
|
2018
Q3 | $1.6M | Buy |
38,342
+341
| +0.9% | +$14.3K | 0.82% | 47 |
|
|
2018
Q2 | $1.31M | Buy |
38,001
+324
| +0.9% | +$11.2K | 0.64% | 53 |
|
|
2018
Q1 | $1.27M | Buy |
37,677
+178
| +0.5% | +$6K | 0.58% | 56 |
|
|
2017
Q4 | $1.29M | Buy |
37,499
+300
| +0.8% | +$10.3K | 0.57% | 58 |
|
|
2017
Q3 | $1.26M | Buy |
37,199
+1,803
| +5% | +$61.1K | 0.63% | 57 |
|
|
2017
Q2 | $1.13M | Buy |
35,396
+772
| +2% | +$24.6K | 0.64% | 54 |
|
|
2017
Q1 | $1.12M | Buy |
+34,624
| New | +$1.12M | 0.66% | 53 |
|